Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study.

ABSTRACT:

Background

Patients with COVID-19 infection are commonly reported to have an increased risk of venous thrombosis. The choice of anti-thrombotic agents and doses are currently being studied in randomized controlled trials and retrospective studies. There exists a need for individualized risk stratification of venous thromboembolism (VTE) to assist clinicians in decision-making on anticoagulation. We sought to identify the risk factors of VTE in COVID-19 patients, which could help physicians in the prevention, early identification, and management of VTE in hospitalized COVID-19 patients and improve clinical outcomes in these patients.

Method

This is a multicenter, retrospective database of four main health systems in Southeast Michigan, United States. We compiled comprehensive

SUBMITTER: Lee Y 

PROVIDER: S-EPMC9100286 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature